Skip to market wire
InvestLog
← Back to Stock Events← 返回个股快讯
NVSRating Change评级变动Media source媒体来源Source link原始来源by InvestLog AIInvestLog AI 整理
Event time: 事件时间：
Published: 文章发布：

Morgan Stanley lowers NVS target to $156 from $170Morgan Stanley 下调目标价 诺华公司 (NVS)：$170 → $156

On 2026-10-06, Morgan Stanley lowered its NVS price target to $156 from $170 (-8.2%).

Morgan Stanley 于 2026-10-06 将 NVS 目标价下调至 $156，此前为 $170，变动幅度 -8.2%。

View NVS stock details ->查看 NVS 个股详情 ->

For information only. Not investment advice.内容仅供参考，不构成投资建议。

Related articles相关阅读

NVS receives FDA approval for as first treatmentNovartis AG（NVS）的 as first treatment 获美国 FDA 批准

Material Company Event · October 7, 2026公司公告 · 2026/10/7

HSBC upgrades NVS from Reduce to HoldHSBC 把 诺华公司 (NVS) 评级 上调：减持（Reduce） → 持有（Hold）

Rating Change · September 10, 2026评级变动 · 2026/9/10

Novartis AG (NVS) falls 12.43% to $140.11Novartis AG（NVS）下跌 12.43%，报 $140.11

Stock Price Move · September 8, 2026个股行情异动 · 2026/9/8